Delivery Order SPE2DR25D1102-SPE2DR26FFA7L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Pfizerpen 5 million unit vials with a ceiling value of $1,551.96 under a firm fixed price contract type. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a competitively awarded, non-set-aside transaction...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20 million unit vials of the antibiotic PFIZERPEN, with a ceiling value of $1,184.80. The contract is a firm fixed-price delivery order with a period of performance through July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $10,385.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 5 million units of Penicillin G Sodium on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $3,693 to Amerisourcebergen Drug Corp for the supply of 5 million units of Pfizerpen vaccine vials. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested vaccine supplies from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by July 27, 2023. No subcontractors or set aside designations were indicated. This delivery order was issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $8,408.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,397.53 for Bicillin L-A 1,200,000 Units 2ML, a penicillin-based antibiotic commonly used for treating bacterial infections. This competitively awarded, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a ceiling value of $1,053.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is set for ultimate completion by December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on December 1, 2025. This firm fixed-price delivery order, valued at $63,643.58, is scheduled for completion by December 2, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $8,886.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25, 6-month to 4-year formulation, 0.9ml) valued at $1,570.70, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of vaccine product to support federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1102Indefinite Delivery Contract
- SPE2DR25D1102-SPE2DR26FFA7LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Pfizerpen 5 Million Unit Vials, with a ceiling value of $1,378.75. This competitively awarded, firm fixed-price delivery order is set to be completed by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is well-positioned to fulfill this antibiotic procurement need for military and defense medical supply chains. The company's extensive portfolio of federal contract awards with the DLA demonstrates its capability to meet rigorous procurement standards and deliver diverse pharmaceutical products, from specialty medications to vaccines and medical supplies, across multiple therapeutic domains. This delivery order exemplifies the operational flexibility of AmerisourceBergen's prime vendor agreement, enabling rapid fulfillment of specific medical commodity requirements for defense health system operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/3/25 |